Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16818276rdf:typepubmed:Citationlld:pubmed
pubmed-article:16818276lifeskim:mentionsumls-concept:C0334634lld:lifeskim
pubmed-article:16818276lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:16818276lifeskim:mentionsumls-concept:C0045093lld:lifeskim
pubmed-article:16818276lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16818276lifeskim:mentionsumls-concept:C1130454lld:lifeskim
pubmed-article:16818276lifeskim:mentionsumls-concept:C0243144lld:lifeskim
pubmed-article:16818276lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:16818276lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:16818276lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:16818276pubmed:issue7lld:pubmed
pubmed-article:16818276pubmed:dateCreated2006-7-4lld:pubmed
pubmed-article:16818276pubmed:abstractTextNucleoside transporters might play a relevant role in the intracellular targeting of many nucleoside analogs used in anticancer therapy. Two gene families (SLC28 and SLC29) encode the two types of human nucleoside transporters, concentrative nucleoside transporter (CNT) and equilibrative nucleoside transporter (ENT) proteins. Chronic lymphocytic leukemia (CLL) cells express both SLC28- and SLC29-related mRNA, although transport function seems to be mostly related to ENT-type transporters. Here we have analyzed the role of nucleoside transporters in nucleoside-derived drug bioavailability and action in mantle cell lymphoma (MCL) cells.lld:pubmed
pubmed-article:16818276pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16818276pubmed:languageenglld:pubmed
pubmed-article:16818276pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16818276pubmed:citationSubsetIMlld:pubmed
pubmed-article:16818276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16818276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16818276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16818276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16818276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16818276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16818276pubmed:statusMEDLINElld:pubmed
pubmed-article:16818276pubmed:monthJullld:pubmed
pubmed-article:16818276pubmed:issn1592-8721lld:pubmed
pubmed-article:16818276pubmed:authorpubmed-author:KochM FMFlld:pubmed
pubmed-article:16818276pubmed:authorpubmed-author:ColomerDolors...lld:pubmed
pubmed-article:16818276pubmed:authorpubmed-author:VillamorNeusNlld:pubmed
pubmed-article:16818276pubmed:authorpubmed-author:CasadoF...lld:pubmed
pubmed-article:16818276pubmed:authorpubmed-author:Pastor-Anglad...lld:pubmed
pubmed-article:16818276pubmed:authorpubmed-author:MarcéSilviaSlld:pubmed
pubmed-article:16818276pubmed:authorpubmed-author:Molina-ArcasM...lld:pubmed
pubmed-article:16818276pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16818276pubmed:volume91lld:pubmed
pubmed-article:16818276pubmed:ownerNLMlld:pubmed
pubmed-article:16818276pubmed:authorsCompleteYlld:pubmed
pubmed-article:16818276pubmed:pagination895-902lld:pubmed
pubmed-article:16818276pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16818276pubmed:meshHeadingpubmed-meshheading:16818276...lld:pubmed
pubmed-article:16818276pubmed:meshHeadingpubmed-meshheading:16818276...lld:pubmed
pubmed-article:16818276pubmed:meshHeadingpubmed-meshheading:16818276...lld:pubmed
pubmed-article:16818276pubmed:meshHeadingpubmed-meshheading:16818276...lld:pubmed
pubmed-article:16818276pubmed:meshHeadingpubmed-meshheading:16818276...lld:pubmed
pubmed-article:16818276pubmed:meshHeadingpubmed-meshheading:16818276...lld:pubmed
pubmed-article:16818276pubmed:meshHeadingpubmed-meshheading:16818276...lld:pubmed
pubmed-article:16818276pubmed:year2006lld:pubmed
pubmed-article:16818276pubmed:articleTitleExpression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma.lld:pubmed
pubmed-article:16818276pubmed:affiliationUnitat d'Hematopatologia, Hospital Cliníc, IDIBAPS, Villarroel 170, 08036 Barcelona, Spain.lld:pubmed
pubmed-article:16818276pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16818276pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2030entrezgene:pubmedpubmed-article:16818276lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16818276lld:entrezgene
lhgdn:association:56428lhgdn:found_inpubmed-article:16818276lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16818276lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16818276lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16818276lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16818276lld:pubmed